SQL & Python Fundamentals
Data engineers face medium-difficulty coding problems focused on data manipulation, ETL logic, and distributed processing algorithms.
0 roles from funded startups and hidden sources. Posted
minutes ago. Updated every 60 seconds
Focus areas that matter most for data engineering positions. Explore key insights and preparation tips to help you excel in your interview process.
Data engineers face medium-difficulty coding problems focused on data manipulation, ETL logic, and distributed processing algorithms.
Design scalable data systems, streaming pipelines, and storage solutions that handle petabyte-scale workloads.
Streaming
Real-time data pipelines
Storage
Data lake & warehouse design
Processing
Distributed computing frameworks
Different companies emphasize different aspects of data engineering based on their scale and business needs.
Netflix
Real-time recommendation pipelines
Stripe
Financial data processing & compliance
Compare cost-of-living buying power and how crowded the market is versus other major tech cities—so you can focus your search where the odds fit your goals.
Philadelphia offers 65% lower housing costs compared to San Francisco, with median home prices around $200K versus $1.2M in the Bay Area. Your data engineering salary stretches significantly further, enabling homeownership and higher savings rates while maintaining access to major East Coast tech opportunities.
Philadelphia's data engineering market is less saturated than major tech hubs, offering better opportunities for career advancement and competitive positioning.

New roles go live every minute and the earliest applicants win. Get the freshest, verified listings delivered straight to your inbox before most job seekers ever see them.
👉 Get free daily job postsVerismo Therapeutics is a clinical-stage cell therapy company developing a multi-chain KIR-CAR platform that adapts NK-cell killer immunoglobulin-like receptor and DAP12 signaling to extend CAR T cell therapy beyond blood cancers into solid tumors. Founded by inventors of the Kymriah CAR-T (including Carl June), the company is advancing two Phase 1 programs: SynKIR-110 in mesothelin-positive solid tumors and SynKIR-310 in relapsed/refractory B cell non-Hodgkin lymphoma. It is a U.S. subsidiary of KOSDAQ-listed HLB Innovation.
Raised
$28M
Series B · 2026
Key contacts
-
Leadership & hiring contacts indexed
HQ market
Philadelphia, Pennsylvania
United States
Philadelphia-based healthcare technology company providing AI-driven automation for prior authorization. The platform stitches together the healthcare ecosystem by empowering providers and health systems to navigate the prior authorization process more efficiently, reducing administrative burden and accelerating patient access to care.
Raised
$8.5M
Series A · 2026
Key contacts
-
Leadership & hiring contacts indexed
HQ market
Philadelphia , Pennsylvania
United States